Vladimir Trusov - SLA AX Insider

SLA AX -- Australia Stock  

 0.039  0.00  0.00%

Head of Medical Development - Russia

We currently do not have informatin regarding Vladimir Trusov. This executive tanure with SLA AX is not currenlty determined.
61 3 9820 2699  http://www.solagran.com

Management Efficiency

The company has return on total asset (ROA) of (21.17) % which means that it has lost $21.17 on every $100 spent on asset. This is way below average.
The company has accumulated 7.26 M in total debt with debt to equity ratio (D/E) of 0.39 which is about average as compared to similar companies. SLA AX has Current Ratio of 1.18 suggesting that it may have difficulties to pay its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Solagran Limited, a biotechnology company, engages in the research and commercial development of Bioeffectives, as well as patent protection for the extraction and application of Bioeffectives. SLA AX (SLA) is traded on Australian Securities Exchange in Australia. It is located in Melbourne, VIC and employs 10 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add SLA AX to your portfolio

Top Management

SLA AX Leadership Team

Stock Performance

SLA AX Performance Indicators